Efficacy and Safety Study of Trastuzumab, Paclitaxel and Carboplatin on HER2+ Preoperative Breast Cancer
NCT01170143
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Trastuzumab QW, Trastuzumab Q3W
Sponsor
Fudan University
Collaborators
[object Object]